Superior Fusion Success at 12 Months: CCF achieved a 61.0% composite fusion success rate compared to just 17% in the ACDF group—a nearly fourfold improvement (p<0.001). Fusion was strictly defined by ...

SELF-CERV study validates the Teal Wand at-home cervical cancer screening as a preferred and viable alternative to in-person screening. Key clinical findings from the Teal Health SELF-CERV study ...

The study, published in the International Journal of Cancer, found that point-of-care tests have the potential to become ...

The final analysis of the largest efficacy trial of a cervical cancer vaccine is published today in The Lancet. The study, involving 18,644 women, confirmed GlaxoSmithKline's Cervarix ®is highly ...

Geneva, Switzerland: Two large, landmark radiotherapy studies have shown that it is possible to treat cervical cancer effectively with high doses specifically adapted to each tumour, and with fewer ...

This article is authored by Dr Ravi Mehrotra and Abantika Ghosh.

The recent launch of the human papilloma virus (HPV) vaccine programme by the Prime Minister in Ajmer is a cherished milestone in India’s public health approach to cervical cancer prevention. To ...

VENLO, Netherlands, April 1 /PRNewswire-FirstCall/ -- Results from an eight-year trial involving more than 130,000 women published today in The New England Journal of ...